AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s stock price hit a new 52-week low on Monday . The company traded as low as $7.40 and last traded at $7.59, with a volume of 824 shares changing hands. The stock had previously closed at $7.79.
Analysts Set New Price Targets
AHCO has been the subject of a number of analyst reports. Royal Bank of Canada boosted their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Canaccord Genuity Group increased their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. UBS Group reduced their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Robert W. Baird upped their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Finally, Truist Financial increased their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth presently has a consensus rating of "Buy" and a consensus price target of $13.80.
Get Our Latest Report on AHCO
AdaptHealth Stock Up 3.9 %
The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The firm has a market cap of $1.08 billion, a PE ratio of -4.87, a PEG ratio of 1.08 and a beta of 1.44. The company's 50 day moving average price is $9.61 and its two-hundred day moving average price is $9.91.
Institutional Trading of AdaptHealth
Institutional investors have recently made changes to their positions in the business. Blue Trust Inc. lifted its position in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares in the last quarter. SummerHaven Investment Management LLC lifted its holdings in AdaptHealth by 1.7% during the 1st quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company's stock worth $866,000 after buying an additional 1,329 shares during the last quarter. Guggenheim Capital LLC increased its stake in AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after purchasing an additional 1,525 shares during the last quarter. Sterling Capital Management LLC raised its stake in AdaptHealth by 5.2% during the 4th quarter. Sterling Capital Management LLC now owns 33,558 shares of the company's stock worth $319,000 after acquiring an additional 1,644 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock valued at $121,000 after purchasing an additional 1,690 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company's stock.
About AdaptHealth
(
Get Free Report)
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Articles
Before you consider AdaptHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.
While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.